Diagnosis, prevention, and treatment of adverse reactions to aspirin and nonsteroidal anti-inflammatory drugs
References (23)
- et al.
Aspirin intolerance in asthma, detection by oral challenge
J Allergy Clin Immunol
(1972) - et al.
Aspirin and concomitant idiosyncracies in adult asthmatic patients
J Allergy Clin Immunol
(1979) - et al.
Concerning the nature of intolerance to aspirin
J Allergy Clin Immunol
(1967) Presidential message: The need to re-evaluate acetylsalicylic acid (aspirin)
J Allergy Clin Immunol
(1970)- et al.
Aspirin-sensitive rhinosinusitis/asthma: spectrum of adverse reactions to aspirin
J Allergy Clin Immunol
(1983) - et al.
Incidence of bronchoconstriction due to aspirin, azo dyes, non-azo dyes and preservatives in a population of perennial asthmatics
J Allergy Clin Immunol
(1979) - et al.
Aspirin-sensitive rhinosinusitis: The clinical syndrome and effects of aspirin administration
J Allergy Clin Immunol
(1983) - et al.
Clinical patterns of hypersensitivity to nonsteroidal anti-inflammatory drugs and their pathogenesis
J Allergy Clin Immunol
(1977) - et al.
Hypersensitivity to nonsteroidal anti-inflammatory drugs: Indications and methods for oral challenges
J Allergy Clin Immunol
(1979) - et al.
Benoxaprofen, an inhibitor of arachidonic acid lipoxygenase, does not prevent aspirin sensitive asthma
J Allergy Clin Immunol
(1982)
Aspirin desensitization in aspirin-sensitive asthmatic patients: Clinical manifestations and characterization of the refractory period
J Allergy Clin Immunol
(1982)
Cited by (198)
Omalizumab ameliorates extrarespiratory symptoms in patients with aspirin-exacerbated respiratory disease
2023, Journal of Allergy and Clinical ImmunologyA 1-Day, 90-Minute Aspirin Challenge and Desensitization Protocol in Aspirin-Exacerbated Respiratory Disease
2019, Journal of Allergy and Clinical Immunology: In PracticeCitation Excerpt :Although nonsteroidal anti-inflammatory drug avoidance is recommended for AERD, patients who require aspirin therapy for refractory nasal polyposis, difficult to control asthma, or inflammatory or cardiovascular disease can undergo aspirin challenge and desensitization.1 Aspirin challenge and desensitization requires delivering escalating doses of aspirin or another COX-1 inhibitor to patients with AERD, provoking a reaction, persisting to establish tolerance, and then continuing long-term therapy without interruption.2 Patients are then able to benefit from the therapeutic effects of high-dose aspirin.
Other NSAIDs Reactions
2018, Drug Allergy TestingSmoking Cessation as a Possible Risk Factor for the Development of Aspirin-Exacerbated Respiratory Disease in Smokers
2018, Journal of Allergy and Clinical Immunology: In PracticeOther NSAIDs Reactions
2017, Drug Allergy TestingTolerance to nonsteroidal anti-inflammatory drugs and alcohol after omalizumab treatment in a patient with chronic urticaria
2016, Annals of Allergy, Asthma and Immunology
Copyright © 1984 Published by Mosby, Inc.